Psychotic Disorder Clinical Trial
Official title:
Brief Mindfulness-Based Family Psychoeducation Intervention for Chinese Students With Early Psychosis: A Mixed Methods Study
Verified date | February 2024 |
Source | The Hong Kong Polytechnic University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
A brief Mindfulness-Based Family Psychoeducation programme is developed to reduce the caregiver's stress and to promote young people's recovery. A randomized controlled trial will be conducted to compare a mindfulness-based family psychoeducation intervention, with an ordinary family psychoeducation intervention. 300 caregivers of a youth who have experienced early psychosis will be recruited. Programme effectiveness will be assessed by comparing outcomes measuring caregiver's perceived stress, positive well-being, and the young people's mental health symptoms. As part of the programme activity, Photovoice approach is selected to explore the complex family experiences and the benefits of mindfulness from the caregiver's personal perspectives. Caregivers can offer their voices about their burdens, and how mindfulness can benefit to the families through their involvement in a photo taking activity during the psychoeducation programme.
Status | Completed |
Enrollment | 80 |
Est. completion date | December 30, 2022 |
Est. primary completion date | December 30, 2022 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - caregivers of a youth under the age of 35 and who has experienced EP, or has a diagnosis of SMI, in the last three years - caregivers who have offered the care to the student for at least one year. Exclusion Criteria: - caregivers who have diagnoses of SMI or developmental disabilities, such as intellectual disabilities, which may present difficulties in comprehending the content of the programme. - both caregivers and youth who refuse to receive regular psychiatric consultation. |
Country | Name | City | State |
---|---|---|---|
Hong Kong | The Hong Kong Polytechnic University | Hong Kong |
Lead Sponsor | Collaborator |
---|---|
The Hong Kong Polytechnic University |
Hong Kong,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change from baseline caregiver's general stress level at 6 weeks and at 12 months | Measured by Zarit Burden Interview (ZBI) (22 items) (Zarit, Reever, Bach-Peterson 1980), assessing caregivers' subjective burden. The total score ranges from 0 (low burden) to 88 (high burden). | (1) Pretest baseline, (2) through intervention completion, 6 weeks, and (3) 12-month follow up after intervention completion | |
Secondary | Change from baseline caregiver's caregiving experiences at 6 weeks and at 12 months | Measured by Experience of Caregiving Inventory (Szmukler et al., 1996), with selected subscales of Stigma (5 items), Effects on the Family (7 items), Positive Experience in Caregiving (14 items), assessing caregivers' experience in the caregiving relationship.
The Stigma score ranges from 0 (little experience of stigma) to 20 (much experience of stigma). The Effects on the Family score ranges from 0 (little negative effects on the family) to 28 (much negative effects on the family). The Positive Experience in Caregiving score ranges from 0 (little positive experience in caregiving) to 56 (much positive experience in caregiving). No total scores are calculated. |
(1) Pretest baseline, (2) through intervention completion, 6 weeks, and (3) 12-month follow up after intervention completion | |
Secondary | Change from baseline caregiver's physical health and mental health at 6 weeks and at 12 months | Physical health measured by 14 item, Physical Distress subscale in Body-Mind-Spirit Well-Being Inventory (Ng et al., 2005), assessing caregivers' level of subjective distress caused by specific physical symptoms; mental health, i.e., Anxiety and Depression, measured by Hospital Anxiety and Depression Scale (Zigmond & Snaith, 1983), assessing caregivers' severity of anxiety and depression.
The Physical Distress score ranges from 0 (low distress) to 140 (high distress). The Anxiety score ranges from 0 (low anxiety) to 21 (high anxiety). The Depression score ranges from 0 (low depression) to 21 (high depression). No total scores are calculated. |
(1) Pretest baseline, (2) through intervention completion, 6 weeks, and (3) 12-month follow up after intervention completion | |
Secondary | Change from baseline caregiver's well-being at 6 weeks and at 12 months | Measured by WHO-5 Well-Being Index (Johansen, 1998), assessing caregivers' emotional well-being.
The total score ranges from 0 (bad well-being) to 25 (good well-being). |
(1) Pretest baseline, (2) through intervention completion, 6 weeks, and (3) 12-month follow up after intervention completion | |
Secondary | Change from baseline caregiver's perceived family functioning at 6 weeks and at 12 months | Measured by 5 item, Family APGAR Scale (Smilkstein, Ashworth, & Montano, 1982), with five subscales in adaptation, partnership, growth, affection and resolve, assessing parent's satisfaction of family functions.
The total score ranges from 0 (dissatisfaction) to 10 (good satisfaction). |
(1) Pretest baseline, (2) through intervention completion, 6 weeks, and (3) 12-month follow up after intervention completion | |
Secondary | Change from baseline youth's recovery at 6 weeks and at 12 months | Measured by Mental Health Recovery Measure (Young & Bullock, 2005), with 30 items in eight subscales relating to positive dimensions in recovery including Overcoming Stuckness (OS; 4 items), Self-Empowerment (SE; 4 items), Learning and Self-Redefinition (LSR; 4 items), Basic Functioning (BF; 4 items), Overall Well-Being (OWB; 4 items), New Potentials (NP; 4 items), Advocacy/Enrichment (A/E; 4 items) and Spirituality (2 items), assessing recovery-related experiences of people with severe mental illness.
The total score ranges from 0 (bad recovery-related experiences) to 120 (good recovery-related experiences). OS, SE, LSR, BF, OWB, NP and A/E range from 0 (bad recovery-related experiences) to 16 (good recovery-related experiences). Spirituality ranges from 0 (bad recovery-related experiences) to 8 (good recovery-related experiences). Eight subscale scores are summed to compute a total score. |
(1) Pretest baseline, (2) through intervention completion, 6 weeks, and (3) 12-month follow up after intervention completion | |
Secondary | Change from baseline caregiver's interpersonal mindfulness at 6 weeks and at 12 months | Measured by the Interpersonal mindfulness in Parenting Scale (Duncan, 2007), with 23 items in four factors in Compassion for Child (CC), Emotional Awareness in Parenting (EAP), Nonjudgmental Acceptance in Parenting (NAP) and Listening with Full Awareness (LFA) (Lo et al., 2018), assessing caregivers' quality of mindfulness specific to his or her family context.
The total score ranges from 23 (low mindfulness) to 115 (high mindfulness). CC ranges from 7 (low compassion for child) to 35 (high compassion for child). EAP ranges from 6 (low emotional awareness in parenting) to 30 (high emotional awareness in parenting). NAP ranges from 6 (low nonjudgmental acceptance in parenting) to 30 (high nonjudgmental acceptance in parenting). LFA ranges from 4 (less likely listening with full awareness) to 20 (more likely listening with full awareness). Four subscale scores are summed to compute a total score. |
(1) Pretest baseline, (2) through intervention completion, 6 weeks, and (3) 12-month follow up after intervention completion | |
Secondary | Change from baseline caregiver's non-attachment at 6 weeks and at 12 months | Measured by short form (8 items) of Non-attachment Scale (Sahdra, Shaver & Brown, 2010), assessing caregivers' subjective level of nonattachment.
The total score ranges from 8 (low level of nonattachment) to 48 (high level of nonattachment). |
(1) Pretest baseline, (2) through intervention completion, 6 weeks, and (3) 12-month follow up after intervention completion | |
Secondary | Change from baseline youth's expressed emotion at 6 weeks and at 12 months | Measured by 12 item Level of Expressed Emotion Scale (Cole & Kazarian, 1988), with subscales in Criticism (4 items), Hostility (4 items) and Over-Involvement (4 items), assessing patients' perceived expressed emotions from the most influential person.
The total score ranges from 12 (low perceived expressed emotions) to 48 (high perceived expressed emotions). Criticism, Hostility and Over-Involvement scores range from 4 (low perceived expressed emotions from particular sources) to 16 (high perceived expressed emotions from particular sources). Three subscale scores are summed to compute a total score. |
(1) Pretest baseline, (2) through intervention completion, 6 weeks, and (3) 12-month follow up after intervention completion | |
Secondary | Change from baseline youth's psychiatric symptom at 6 weeks and at 12 months | Measured by the Positive and Negative Syndrome Scale (PNSS) (Kay, Flszbein & Opler, 1988), subscales in Positive Scale (7 items), Negative Scale (7 items) and General Psychopathology Scale (16 items), assessing students' psychiatric symptoms.
Positive Scale ranges from 7 (few positive syndromes) to 49 (many positive syndromes). Negative Scale ranges from 7 (few negative syndromes) to 49 (many negative syndromes). General Psychopathology Scale ranges from 16 (few general psychopathological symptoms) to 112 (many). No total scores are calculated. |
(1) Pretest baseline, (2) through intervention completion, 6 weeks, and (3) 12-month follow up after intervention completion |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02306551 -
Well Being And Resilience: Mechanisms of Transmission of Health and Risk
|
||
Active, not recruiting |
NCT00627029 -
Evaluation of Programs of Coordinated Care and Disease Management
|
N/A | |
Terminated |
NCT00049738 -
Screening for Childhood-Onset Psychotic Disorders
|
N/A | |
Withdrawn |
NCT01724372 -
The Role of Antidepressants or Antipsychotics in Preventing Psychosis
|
N/A | |
Completed |
NCT00716755 -
Minimizing Doses of Antipsychotic Medication in Older Patients With Schizophrenia.
|
N/A | |
Completed |
NCT00498550 -
Treatment of Schizophrenia and Comorbid Cannabis Use Disorder: Comparing Clozapine to Treatment-as-Usual
|
Phase 4 | |
Terminated |
NCT04140773 -
The Effect of D-serine as add-on Therapy in Recent-onset Psychosis
|
N/A | |
Completed |
NCT01473550 -
Mental Health Engagement Network (MHEN)
|
N/A | |
Completed |
NCT01207219 -
Yoga and Aerobic Exercise in Psychosis
|
N/A | |
Completed |
NCT00397033 -
Evaluation of Effectiveness and Safety of Paliperidone Extended Release in Patients With Schizoaffective Disorder.
|
Phase 3 | |
Recruiting |
NCT04945278 -
Study of Self-Recognition and Self/Other Distinction Disorders in Patients With Psychological Vulnerability
|
N/A | |
Completed |
NCT03955250 -
Mobile After-Care Support App: Pilot RCT
|
N/A | |
Completed |
NCT00287352 -
Study of Amantadine for Weight Stabilization During Olanzapine Treatment
|
Phase 1 | |
Completed |
NCT00005658 -
Glycine to Treat Psychotic Disorders in Children
|
Phase 2 | |
Terminated |
NCT00169026 -
Alcoholism and Schizophrenia: Effects of Clozapine
|
Phase 4 | |
Completed |
NCT00001482 -
New Drugs in the Treatment of Mood Disorders
|
Phase 2 | |
Terminated |
NCT03671005 -
Mindfulness-based Group Therapy for Inpatients With Schizophrenia Spectrum Disorders
|
N/A | |
Completed |
NCT00156715 -
Efficacy of Quetiapine in the Treatment of Patients With Schizophrenia and a Comorbid Substance Use Disorder
|
Phase 4 | |
Completed |
NCT00095524 -
Effects of Aripiprazole in Overweight Patients Treated With Olanzapine for Schizophrenia or Schizoaffective Disorder
|
Phase 3 | |
Completed |
NCT03667729 -
The Effects of Progressive Muscle Relaxation Therapy in Patients With Schizophrenia
|
N/A |